Methamphetamine/Ecstasy Detection Patent & Product Launch
Cozart plc announced that the UK Patent Office has granted its patent for the detection of the Methamphetamine group of drugs. The technology covered by this patent is used in the new Cozart methamphetamine/ecstasy powders test, one of a family of such tests being launched for sale. Other powders tests in the range include that for cocaine/crack, which is already in use by police and customs authorities in the UK and France, and the newly developed tests for heroin (opiates), amphetamines and cannabis.
The methamphetamine patent (GB2404022) covers innovative reagents that allow the simultaneous detection of the methamphetamine family with high specificity and more importantly without significant interference by many of the structurally related over the counter medicines found in nasal decongestants and bronchial inhalers.
In addition to the new powders test, the patented methamphetamine reagents and test formats can be used as an inherent part of the Cozart® RapiScan system for on site detection of drugs in saliva (oral fluid). This enables the sensitive screening of low levels of the methamphetamine family, which is particularly important in the area of roadside and workplace drug testing.
This patent deals with the complex area of immunochemistry and further patent applications are expected to be filed to extend further the Company's intellectual property portfolio.
Other news from the department research and development
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection

Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.